AOD 9604 is not FDA-approved as a pharmaceutical drug
AOD 9604 (Anti-Obesity Drug 9604) is the commercial development name given to the HGH fragment spanning amino acids 176 through 191, with a tyrosine substitution at the N-terminus replacing the native phenylalanine for stability
Whether you are navigating a complex autoimmune condition or simply looking to optimize your daily performance, our providers ensure your treatment is safe, evidence-based, and perfectly timed
Headaches, nausea, diarrhea, fatigue, and tingling in extremities are very rare
From routine physicals to urgent concerns, our integrated model helps address many needs in one place
For example, growth hormone is implicated in activating bone turnover, increasing body lean mass, and reducing adiposity